AI Article Synopsis

  • Recent cases of severe acetaminophen overdoses have raised concerns about whether the standard dosage of N-acetylcysteine (NAC) is sufficient to prevent liver damage.
  • This study reviewed 104 instances of massive acetaminophen overdose over nearly a decade, confirming that 76% of patients who received standard NAC treatment did not experience liver injury.
  • The findings suggest that administering NAC within 8 hours of overdose is crucial, as those treated after this window showed a significantly higher risk of hepatotoxicity.

Article Abstract

Background: Recent recognition of "massive" acetaminophen (APAP) overdoses has led to the question of whether standard dosing of N-acetylcysteine (NAC) is adequate to prevent hepatoxicity in these patients. The primary aim of this study was to evaluate the clinical outcome for patients with massive APAP overdose who received standard intravenous NAC dosing of 300 mg/kg over 21 h.

Methods: This was a single-center retrospective cohort study conducted by chart review of APAP overdoses reported to a regional poison center from 1 January 2010 to 31 December 2019. Massive APAP overdose was defined by single, acute overdose resulting in an APAP concentration exceeding 300 mcg/mL at 4 h post-ingestion. Standard univariate statistical analysis was conducted to describe the cohort, and a multivariate logistic model was utilized to calculate adjusted odds ratios for risk of hepatoxicity.

Results: 1425 cases of APAP overdose were reviewed. 104 cases met the inclusion criteria of massive APAP overdose. Overall, 79 cases (76%) had no acute liver injury or hepatotoxicity, and 25 (24%) developed hepatoxicity. Nine percent ( = 4) of cases receiving NAC within 8 h developed hepatotoxicity. Crude odds for hepatoxicity was 5.5-fold higher for cases who received NAC after 8 h.

Conclusions: Standard NAC dosing received within 8 h prevented hepatoxicity in 91% ( = 40) of cases in our series of massive APAP overdoses. Additional data is needed to determine the clinical outcomes of massive APAP overdose using current intravenous NAC dosing.

Download full-text PDF

Source
http://dx.doi.org/10.1080/15563650.2021.1887493DOI Listing

Publication Analysis

Top Keywords

massive apap
20
apap overdose
20
apap overdoses
12
nac dosing
12
apap
9
clinical outcome
8
intravenous nac
8
overdose
7
massive
6
nac
6

Similar Publications

PPARβ/δ agonist GW0742 mitigates acute liver damage induced by acetaminophen overdose in mice.

Toxicol Appl Pharmacol

January 2025

Institute of Toxicology, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, China. Electronic address:

Liver damage caused by acetaminophen (APAP) overdose remains a worldwide medical problem. New therapeutic medicines for APAP poisoning are needed as the efficacy of the only antidote, N-acetyl-cysteine (NAC), significantly decreases if administered after 8 h of APAP intake and massive APAP overdose remains to induce hepatotoxicity despite the timely administration of NAC. Peroxisome proliferator-activated receptor β/δ (PPARβ/δ) possesses versatile roles including regulation of lipid homeostasis and anti-inflammation in the liver.

View Article and Find Full Text PDF
Article Synopsis
  • Drug-induced liver injury (DILI) is a serious health issue that can lead to chronic conditions or liver failure, often caused by drug toxicity or immune responses.
  • The article examines how different immune cells contribute to liver damage and healing during DILI, focusing on their roles in inflammation and liver regeneration.
  • It also explores potential therapeutic strategies targeting these immune cells and discusses the significance of liver progenitor cells in recovering from severe liver damage.
View Article and Find Full Text PDF

Cell death is a fundamental process in health and disease. Emerging research shows the existence of numerous distinct cell death modalities with similar and intertwined signaling pathways, but resulting in different cellular outcomes, raising the need to understand the decision-making steps during cell death signaling. Paracetamol (Acetaminophen, APAP)-induced hepatocyte death includes several apoptotic processes but eventually is executed by oncotic necrosis without any caspase activation.

View Article and Find Full Text PDF

Should high-dose N-acetylcysteine be given in cases of massive paracetamol overdoses: A narrative review.

Basic Clin Pharmacol Toxicol

September 2024

Department of Clinical Pharmacology, Copenhagen University Hospital, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.

N-acetylcysteine (NAC) is regarded as an effective treatment of paracetamol overdoses. However, in cases of "massive" paracetamol overdoses, recent studies indicate that patients may not be sufficiently treated with the standard dose of NAC (300 mg/kg over 20-21 h). The subject is further complicated because "massive overdoses" and "high-risk" are defined differently; some studies use the ingested amount (e.

View Article and Find Full Text PDF

Targeting cathepsin C ameliorates murine acetaminophen-induced liver injury.

Theranostics

June 2024

pharmazentrum frankfurt/ZAFES, Institute of General Pharmacology and Toxicology, Faculty of Medicine, Goethe University Frankfurt, Frankfurt am Main, Germany.

Acetaminophen (APAP) overdosing is a major cause of acute liver failure worldwide and an established model for drug-induced acute liver injury (ALI). While studying gene expression during murine APAP-induced ALI by 3'mRNA sequencing (massive analysis of cDNA ends, MACE), we observed splenic mRNA accumulation encoding for the neutrophil serine proteases cathepsin G, neutrophil elastase, and proteinase-3 - all are hierarchically activated by cathepsin C (CtsC). This, along with increased serum levels of these proteases in diseased mice, concurs with the established phenomenon of myeloid cell mobilization during APAP intoxication.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!